Homepage / Programme Live /

From burden to benefit: cost-effectiveness of national type 1 diabetes investment in Kenya - (P-103)

Talk details

Poster Corner 2 THURSDAY: Epidemiology; Economics and Value Addition/access to care
Economics and Value Addition/acces to care
From burden to benefit: cost-effectiveness of national type 1 diabetes investment in Kenya (P-103)
G. K. GATHECHA
06/11/2025 15:15 - 16:15 CEST